Skip to search boxSkip to navigationSkip to main content

Use of mouthwashes against COVID-19 in dentistry

*Corresponding author for this work
Research Output:
Contribution to journal
Review article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 924-927 (4 pages)

Journal (Volume, Issue Number)

British Journal of Oral and Maxillofacial Surgery (Volume 58, Issue 8)

Publication milestones

  • Published - 10/2020

Publication status

Published - 10/2020

ISSN

0266-4356

Publication IDs

  • Scopus: 85089824104
  • PubMed: 32859459

Abstract

The proximity to the patient during dental care, high generation of aerosols, and the identification of SARS-CoV-2 in saliva have suggested the oral cavity as a potential reservoir for COVID-19 transmission. Mouthwashes are widely-used solutions due to their ability to reduce the number of microorganisms in the oral cavity. Although there is still no clinical evidence that they can prevent the transmission of SARS-CoV-2, preoperative antimicrobial mouth rinses with chlorhexidine gluconate (CHX), cetylpyridinium chloride (CPC), povidone-iodine (PVP-I), and hydrogen peroxide (H2O2) have been recommended to reduce the number of microorganisms in aerosols and drops during oral procedures. This paper therefore aims to provide a comprehensive review of the current recommendations on the use of mouthwashes against the COVID-19 pandemic and to analyse the advantages and disadvantages of most conventional antiseptic mouthwashes used in dentistry.

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Mentions
4
Captures
382
Citations
121
Social media
44